Claudio Guarneri

21PUBLICATIONS
110CO-AUTHORS
AllergyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanoscale characterisationPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

|May 29, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.

Riccardo Balestri, Giulia Odorici, Michela Magnano

|Feb 26, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).

Diego Orsini, Dario Graceffa, Martina Burlando

|Jun 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study.

C Bonifati, S Lembo, A G Richetta

|Jan 23, 2024
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS).

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli

|Jul 06, 2023
Facial naevus count in the identification of patients at higher risk of melanoma.

Roberta Giuffrida, Gustavo Zanin Poletto, Fabrizio Guarneri

Pageof 4

Frequent Collaborators

5 joint publications

Manuela Ceccarelli

4 joint publications

Emmanuele Venanzi Rullo

4 joint publications

Laura Macca

4 joint publications

Francesca Prignano